Protect your Workforce with Safety & Convenience of NASOVAC-S4

India’s first Quadrivalent Needle-Free Intranasal Flu Vaccine

1 Billion

Cases of influenza are estimated to occur globally

5% - 10%

Unvaccinated adults are infected annually

20% - 30%

Unvaccinated children are infected annually

Book your Flu Vaccination

NASOVAC-S4

Introducing NASOVAC-S4, India’s FIRST quadrivalent needle-free influenza (seasonal flu) vaccine. Covers 2 Type A (H1N1 and H3N2) & 2 Type B (Victoria and Yamagata lineage)

Benefits

Quadrivalent vaccine that offers broad immune response over trivalent vaccines

Intranasal vaccination mimics the natu ra 1 route of infection

Suitable for individuals aged 2 and above, including diabetic and hypertension patients

Needle-free vaccine which is non-invasive and painless

Double protection with mucosal and systemic immune response

NASOVAC-S4 Product Details

NASOVAC-S4 is a live attenuated quadrivalent vaccine that protects from four virus strains

Dosage

A single intranasal dose of 0.5 ml, administered as 0.25 ml per nostril

Storage Requirement

Storage Requirements: Store in a refrigerator at 2ºC – 8ºC. Do not freeze

NASOVAC-S4 Administration Method

Administering NASOVAC-S4 is simple and convenient. Follow these easy steps